Victor L Thijssen

12PUBLICATIONS
34CO-AUTHORS
GlycoconjugatesMolecular targetsPredictive and prognostic markersCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 16, 2025
Ligand-specific tuning of CLEC10A signalling strength and dendritic cell responses through engagement of different GalNAc-containing glycan structures.

Nadia L van der Meijs, Remi Hatinguais, Mike de Kok

|Feb 26, 2025
Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET-Guided Verification.

Suzanne van der Gaag, Tamara Jordens, Maqsood Yaqub

|Dec 11, 2022
Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives.

Tesfay M Godefa, Sarah Derks, Victor L J L Thijssen

|Nov 11, 2022
C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration.

Leonie Hartl, Pien A F Maarschalkerweerd, Joe M Butler

|Sep 23, 2022
Galectokines: The Promiscuous Relationship between Galectins and Cytokines.

Lucía Sanjurjo, Esmee C Broekhuizen, Rory R Koenen

|Jul 27, 2022
Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients.

I H Bartelink, E A van de Stadt, A F Leeuwerik

Pageof 2

Frequent Collaborators

2 joint publications

Imke H Bartelink

2 joint publications

Rory R Koenen

2 joint publications

Lucía Sanjurjo

2 joint publications

Tesfay M Godefa